Formulary Policy Development

Formulary Policy Development is a systematic framework within health care pharmacy management that establishes criteria and processes for selecting, evaluating, and approving medications to be included in a formulary system, thereby distinguishing it from ad hoc or non-structured medication adoption practices.

12

Publications

539

Citations

47

Authors

27

Institutions

Publications per year

2017–2026

1

Authors

47

  1. JP
    John P. Santell

    American Society of Health-System Pharmacists, United States

    2 publications · 118 citations

    2

    h-index

  2. PJ
    Philip J. Schneider

    The Ohio State University, United States

    2 publications · 118 citations

    2

    h-index

  3. CA
    Craig A. Pedersen

    The Ohio State University, United States

    1 publications · 80 citations

    1

    h-index

  4. AS
    Anja Sparre Kristiansen

    University of Southern Denmark, Denmark

    1 publications · 20 citations

    1

    h-index

  5. EP
    Emily Pherson

    Johns Hopkins University, United States

    1 publications · 41 citations

    1

    h-index

1–5 of 47

Venues

  1. American Journal of Health-System Pharmacy

    AJHP · 5 publications · 408 citations

    5

    h-index

  2. Pharmacy World & Science

    PWS · 1 publications · 26 citations

    1

    h-index

  3. Canadian Public Policy

    CPP · 1 publications · 15 citations

    1

    h-index

  4. Journal of Oncology Practice

    JOP · 1 publications · 15 citations

    1

    h-index

  5. PubMed

    Repository · 1 publications · 16 citations

    1

    h-index

1–5